NT Mobile Menu

Search form



Migraine Therapy

A quick overview of what's new (and what to expect) in migraine prevention. ©IrinaBraga/ Shutterstock

Recent Content

Dr. Loeb summarizes a global and one-of-a-kind approach of biomarker and drug discovery using systems biology of human brain tissues.

OI may serve for research purposes as a simple and inexpensive indicator of evolving AD pathology. Details here.

New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.

Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.

Just how private is that information your patient records in a mobile headache diary?

Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.

If you are thinking of adding telemedicine to your practice, here are the benefits—and things to consider.

By clicking Accept, you agree to become a member of the UBM Medica Community.